Used primarily in the synthesis of pharmaceuticals, particularly in the development of active pharmaceutical ingredients (APIs) for therapeutic drugs. It serves as a key intermediate in the production of compounds targeting specific diseases, such as cancer or central nervous system disorders. The trifluoromethyl group enhances the metabolic stability and bioavailability of the resulting drugs. Additionally, it is employed in agrochemical research to create novel pesticides or herbicides, leveraging its structural properties to improve efficacy and selectivity. Its application extends to material science, where it is used in the development of advanced polymers and coatings with specialized properties.